Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04301011
Title Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors (RAPTOR)
Acronym RAPTOR
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Turnstone Biologics, Corp.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Mayo Clinic Phoenix Arizona 85054 United States Details
Mayo Clinic Jacksonville Florida 32224 United States Details
Sylvester Comprehensive Cancer Center / UMHC Miami Florida 33136 United States Details
University of Kansas Medical Center Kansas City Kansas 66205 United States Details
Clinical Site 1007 Boston Massachusetts 02215 United States Details
Mayo Clinic Rochester Minnesota 55902 United States Details
The Billings Clinic Billings Montana 31031 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Ottawa Hospital and Research Institute (OHRI) Ottawa Ontario Canada Details
National Cancer Center Ilsandong 10408 Korea, Republic of Details
Seoul National University Hospital (SNUH) Junggu 03080 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field